#1 Clinical Trials Search in Europe

Infection in an immunocompromised host – Diagnostics

Go back

Diagnosing infections in people with weakened immune systems requires careful attention and specialized testing, as these patients may not show typical signs of illness and face higher risks of serious complications.

Introduction: Who Should Seek Diagnostic Testing

If you have a condition or take medications that weaken your immune system, understanding when to seek medical attention for possible infections becomes especially important. People with compromised immune systems—also called immunocompromised individuals—cannot fight infections as effectively as others, making early detection critical for successful treatment.[1]

You should consider diagnostic testing if you experience any signs of infection, even mild ones. The challenge is that typical infection symptoms might not appear the way they do in healthy people. Sometimes fever may be the only warning sign that something is wrong. Because your body’s usual defense responses may be dampened, redness, swelling, and other common indicators of infection at the site might be absent or very subtle.[3]

Certain groups of people need to be particularly vigilant about seeking diagnostic evaluation. These include individuals receiving chemotherapy or radiation therapy for cancer treatment, those taking long-term steroid medications for conditions like asthma or rheumatoid arthritis, people who have had organ or bone marrow transplants, individuals with HIV infection or AIDS, those with diabetes, and people with primary immune deficiency disorders they were born with.[4]

The timing of diagnostic testing matters greatly for immunocompromised patients. If you develop a fever and have low white blood cell counts, you should report this immediately to your healthcare provider. Many healthcare teams ask these patients to come to the hospital right away for evaluation and treatment with intravenous antibiotics, because infections can progress rapidly from a simple fever to a life-threatening condition called sepsis, where the body’s response to infection damages its own tissues.[3]

⚠️ Important
If you are immunocompromised and develop a fever, do not wait to see if it goes away on its own. Contact your healthcare provider immediately, as infections can spread quickly through your body when your immune defenses are weak. In the absence of infection-fighting white blood cells, what starts as a simple fever can rapidly progress to sepsis and become life-threatening within hours.[3]

People with weakened immune systems should also seek diagnostic testing when they develop respiratory symptoms like cough or shortness of breath, digestive problems including diarrhea, skin changes or wounds that don’t heal normally, or any unusual symptoms that persist longer than expected. Even illnesses that seem minor—like what appears to be a common cold—can become serious in someone whose immune system is compromised.[4]

Classic Diagnostic Methods for Identifying Infections

Diagnosing infections in immunocompromised patients involves a combination of physical examination, patient history, and various laboratory tests. Healthcare providers must consider the specific type of immune deficiency when interpreting test results, as this determines which infections are most likely to occur and how they might present.[1]

Understanding Your Immune Deficiency Type

The first step in proper diagnosis is understanding exactly what part of your immune system is weakened. The immune system has different components that protect against different types of germs. Some people have problems with B cells, which are immune cells that make antibodies—proteins that recognize and help destroy bacteria and viruses. Others have defects in T cells, which directly attack infected cells and help coordinate other immune responses. Some patients have problems with both B and T cells, while others have issues with phagocytes—cells that eat and destroy germs—or with the complement system, a group of proteins that help antibodies and phagocytes clear pathogens from the body.[1]

Each type of immune deficiency makes you susceptible to specific kinds of infections. For example, if you have B-cell defects, you are more prone to frequent sinus, lung, and respiratory tract infections, as well as infections with certain viruses. People with T-cell problems tend to get infections with fungi like Candida (which causes thrush), certain bacteria like Mycobacterium, and viruses from the herpes family. Those with phagocyte problems often develop infections with bacteria such as Staphylococcus aureus (staph infections), Pseudomonas, and fungi like Aspergillus.[2]

Blood Tests

Blood testing forms the foundation of diagnostic evaluation for immunocompromised patients with suspected infections. A complete blood count (CBC) measures the numbers of different types of blood cells, including white blood cells that fight infection. Low white blood cell counts indicate that your body has fewer defenders available to fight off germs. However, some immunocompromised patients may have normal cell counts but the cells don’t function properly, so additional tests may be needed.[4]

Blood cultures are particularly important tests where samples of your blood are placed in special containers that encourage bacteria or fungi to grow. If organisms grow, the laboratory can identify exactly what type of germ is causing your infection and test which antibiotics will work best against it. For immunocompromised patients, blood cultures may need to be repeated multiple times because infections can be harder to detect.[2]

Other blood tests may measure markers of inflammation in your body, such as C-reactive protein or erythrocyte sedimentation rate, which become elevated when infection is present. However, in severely immunocompromised patients, these markers may not rise as high as they would in healthy people, making interpretation challenging for healthcare providers.[4]

Molecular Testing

Molecular tests detect genetic material from viruses, bacteria, or other pathogens directly in body samples. These tests, often called PCR (polymerase chain reaction) tests, are especially valuable for immunocompromised patients because they don’t rely on your immune system producing antibodies. Some immunocompromised individuals cannot make antibodies effectively, which can lead to false-negative results on antibody-based tests.[9]

For patients taking certain immunosuppressive medications—particularly drugs like rituximab that deplete B cells—molecular testing becomes critically important. These patients have an impaired antibody response, which decreases the likelihood of detecting antibodies using standard blood tests. Diagnosis often requires PCR testing to detect viral genetic material in blood, cerebrospinal fluid (the fluid surrounding the brain and spinal cord), or tissue samples.[9]

Imaging Studies

Various imaging tests help visualize infections inside the body that cannot be seen from the outside. Chest X-rays are commonly used to look for pneumonia in the lungs, though immunocompromised patients may develop unusual forms of pneumonia that appear different from typical infections. CT scans (computed tomography) provide more detailed three-dimensional images and can reveal infections in the lungs, abdomen, sinuses, or brain that might be missed on regular X-rays.[2]

For certain types of infections, particularly fungal infections that can spread throughout the body, healthcare providers may order specialized scans. These imaging studies help determine whether an infection that started in one location has spread to other organs, which affects treatment decisions and prognosis.[2]

Cultures and Microscopy

When you have symptoms suggesting infection in specific body areas, your healthcare provider may collect samples from those sites for testing. Sputum (mucus coughed up from the lungs) can be tested for bacteria, fungi, or tuberculosis. Urine samples help diagnose urinary tract infections and kidney infections. Stool samples can identify bacteria, parasites, or viruses causing diarrhea—a common problem in immunocompromised patients that can be caused by organisms like Cryptosporidium or Clostridium difficile.[2]

Sometimes healthcare providers need to obtain samples from deeper body sites through procedures like lumbar puncture (spinal tap) to collect cerebrospinal fluid when brain or spinal cord infection is suspected, or bronchoscopy where a thin tube with a camera is inserted through your mouth or nose into your airways to collect samples directly from the lungs. Though these procedures sound intimidating, they are often necessary for immunocompromised patients who may have infections that don’t show up in simpler tests.[2]

Laboratory technicians examine these samples under microscopes and grow them in culture to identify specific organisms. This process can take several days, but it provides crucial information about which germs are present and which medications will effectively treat them.[2]

Antibody Testing

Antibody tests, also called serological tests, detect antibodies your immune system produces in response to specific infections. These tests can show whether you’ve been exposed to certain viruses or bacteria in the past. However, for immunocompromised individuals, antibody testing has important limitations. If your immune system cannot produce antibodies normally, these tests may give falsely negative results even when you actually have an infection.[9]

Healthcare providers must interpret antibody test results carefully in immunocompromised patients, considering the type and degree of immune suppression. In some cases, the absence of antibodies doesn’t mean you weren’t infected—it may simply mean your weakened immune system couldn’t mount an antibody response.[9]

Biopsies

When other tests cannot identify the cause of illness, or when unusual infections are suspected, your doctor may recommend a biopsy—removing a small piece of tissue for examination under a microscope. Biopsies can be performed on lymph nodes, skin lesions, lung tissue, liver, or other organs depending on where infection is suspected. This procedure allows pathologists to see directly whether infection is present and sometimes identify the specific organism causing it, especially for unusual fungal or mycobacterial infections that are more common in immunocompromised patients.[2]

Diagnostics for Clinical Trial Qualification

When immunocompromised patients are considered for participation in clinical trials, they must undergo specific diagnostic tests to determine eligibility. These standardized assessments ensure that participants meet the study criteria and can be safely monitored throughout the trial period.[2]

Baseline Immune Function Assessment

Clinical trials typically require comprehensive evaluation of your immune system status before enrollment. This includes detailed blood work measuring specific immune cell populations, particularly CD4+ T cell counts for HIV-infected patients, absolute lymphocyte counts, and immunoglobulin levels. These measurements establish your baseline immune function and help researchers understand how your immune deficiency might affect your response to the intervention being studied.[2]

For patients with primary immunodeficiency disorders—conditions you were born with that affect immune function—genetic testing may be required to confirm the specific diagnosis and categorize the type of immune defect. This information helps trial coordinators predict which infections you might be most susceptible to during the study and plan appropriate monitoring.[2]

Infection Screening

Before entering most clinical trials, immunocompromised patients must be screened for active infections. This typically includes testing for tuberculosis using skin tests or blood tests that measure immune response to tuberculosis proteins. Chest X-rays may be required to rule out active lung infections. Blood tests screen for viral infections like HIV, hepatitis B, and hepatitis C, which could affect both your safety during the trial and the interpretation of results.[2]

For trials involving new treatments or vaccines, more extensive infection screening may be needed. This could include testing for cytomegalovirus (CMV), Epstein-Barr virus (EBV), and other viruses that commonly reactivate in immunocompromised individuals. The presence or absence of past exposure to these viruses, shown by antibody testing, may determine whether you can participate in certain studies.[2]

Organ Function Testing

Clinical trials require documentation that your major organs are functioning adequately to handle the study medication or procedure. Standard tests include blood tests measuring kidney function (creatinine and blood urea nitrogen), liver function tests (measuring liver enzymes and bilirubin), and tests assessing bone marrow function through complete blood counts. These baseline measurements are repeated during the trial to detect any adverse effects early.[2]

Heart function may be evaluated through electrocardiograms (ECGs) that record the electrical activity of your heart, and sometimes echocardiograms (ultrasounds of the heart) to ensure your heart can tolerate the study treatment. Lung function tests measuring how well you breathe may be required for trials involving medications that could affect respiratory function.[2]

Molecular and Genetic Testing

Some clinical trials, particularly those testing targeted therapies for cancer or specific treatments for viral infections, require molecular testing to identify whether you have specific genetic markers or mutations. For cancer trials, this might include testing tumor tissue for particular genetic changes that indicate your cancer would likely respond to the experimental treatment. These tests are called companion diagnostics because they help match patients to treatments most likely to benefit them.[2]

For infectious disease trials in immunocompromised patients, molecular testing might determine which strain of virus you’re infected with or whether the pathogen has mutations that make it resistant to standard treatments. This information helps researchers understand whether experimental therapies might work better than existing options.[2]

⚠️ Important
If you’re considering participation in a clinical trial, be prepared for extensive diagnostic testing before enrollment and throughout the study period. While this may seem burdensome, these tests are designed to protect your safety and help researchers gather accurate information. Always ask your clinical trial coordinator to explain which tests are required and why, so you understand how each assessment contributes to your care and the research.[2]

Ongoing Monitoring Requirements

Once enrolled in a clinical trial, immunocompromised patients typically undergo regular diagnostic testing to monitor their health and detect problems early. This includes frequent blood tests, often weekly or monthly depending on the study protocol, to check immune cell counts, organ function, and signs of infection or other complications. Any fever or new symptom usually triggers additional diagnostic workup to quickly identify and treat infections before they become serious.[2]

Some trials require periodic imaging studies—such as CT scans or MRIs—at specific time points to assess treatment response or screen for complications. These scheduled assessments follow standardized protocols so that all participants receive consistent evaluation, making study results more reliable and comparable.[2]

Documentation and Reporting

Clinical trials involving immunocompromised patients must document and report any infections that occur during the study. This requires confirming suspected infections through appropriate diagnostic testing and reporting the results to both the study team and regulatory authorities. This careful tracking helps researchers understand the safety profile of experimental treatments and identify any increased infection risks associated with the therapy being studied.[2]

Timely diagnosis of infections during clinical trial participation is especially important because it enables appropriate clinical management, helps determine whether the infection is related to the study treatment, and contributes to the overall understanding of how experimental therapies affect immunocompromised patients. Your participation in this careful monitoring contributes valuable information that may help future patients with similar conditions.[9]

Prognosis and Survival Rate

Prognosis

The outlook for immunocompromised patients who develop infections varies widely depending on several factors. The type of immune deficiency you have, the specific infection you contract, how quickly the infection is diagnosed and treated, and your overall health status all influence your prognosis. Some infections that are easily treatable in healthy people can become severe or life-threatening in those with weakened immune systems.[3]

The severity of immunosuppression plays a major role in determining outcomes. Patients with mild immune compromise may experience longer recovery times but generally respond well to treatment. However, those with severe immunosuppression—particularly people receiving intensive chemotherapy, those with advanced HIV infection, or patients taking strong B-cell depleting medications—face higher risks of serious complications and poorer outcomes when infections occur.[9]

Timely diagnosis and treatment significantly improve prognosis. When infections are caught early through prompt diagnostic testing and appropriate treatment begins quickly, outcomes improve substantially. This is why immunocompromised patients are advised to seek medical attention immediately for any fever or concerning symptoms rather than waiting to see if the problem resolves on its own.[3]

The specific pathogen causing infection also affects prognosis. Common bacterial infections that respond well to antibiotics generally have good outcomes if treated promptly. However, certain opportunistic infections—particularly some fungal infections, parasitic infections, and viral infections—can be more difficult to treat and may have less favorable outcomes even with appropriate therapy.[2]

Patients who receive appropriate preventive measures, including vaccinations for themselves and their close contacts, practice careful hygiene, and follow infection prevention strategies tend to have better long-term outcomes. Preventing infections in the first place is always preferable to treating them after they occur, especially for severely immunocompromised individuals.[5]

Survival rate

Survival rates for immunocompromised patients with infections vary tremendously based on many factors, making it difficult to provide broadly applicable statistics. The type of underlying condition causing immunosuppression, the severity of immune dysfunction, the specific infection involved, and how quickly treatment begins all influence survival.[3]

According to medical reports, patients taking rituximab—a B-cell depleting medication—who develop certain serious viral brain infections face particularly concerning statistics. In one case series documented by the CDC, four out of five such patients died from arboviral neuroinvasive disease (viral infections affecting the brain and nervous system). Those who survived often experienced long-term disabilities including cognitive problems and motor dysfunction.[9]

When infections progress to sepsis—a life-threatening condition where the body’s response to infection causes widespread inflammation and organ damage—survival depends on rapid recognition and treatment. Severe sepsis and septic shock can leave long-lasting health problems in survivors and are significant causes of death among immunocompromised patients.[5]

It’s important to understand that many immunocompromised patients do successfully fight infections and recover completely, especially when infections are caught early and treated appropriately. The frightening statistics apply primarily to delayed diagnosis, severe infections, or particular high-risk situations. Aggressive prevention strategies and prompt attention to any signs of infection remain the best approaches for ensuring positive outcomes.[3]

Ongoing Clinical Trials on Infection in an immunocompromised host

References

https://pmc.ncbi.nlm.nih.gov/articles/PMC8428766/

https://emedicine.medscape.com/article/973120-overview

https://www.osfhealthcare.org/hospitals/childrens/programs-services/cancer/patient-information-education/infections-immunocompromised-patients

https://my.clevelandclinic.org/health/diseases/immunocompromised

https://www.sepsis.org/infection-prevention-in-immunocompromised-people/

https://text.apic.org/toc/microbiology-and-risk-factors-for-transmission/the-immunocompromised-host

https://www.dzif.de/en/infections-immunocompromised-host

https://pubmed.ncbi.nlm.nih.gov/35785782/

https://www.cdc.gov/vector-borne-diseases/hcp/clinical-guidance-immunocompromised/index.html

https://my.clevelandclinic.org/health/diseases/immunocompromised

https://pmc.ncbi.nlm.nih.gov/articles/PMC8428766/

https://emedicine.medscape.com/article/973120-overview

https://www.autoimmuneinstitute.org/articles/a-guide-for-immunocompromised-individuals-in-a-post-pandemic-world

https://www.webmd.com/a-to-z-guides/ss/slideshow-what-not-to-do-immunocompromised

https://www.healthline.com/health/staying-healthy-while-immunocompromised

https://www.sepsis.org/infection-prevention-in-immunocompromised-people/

https://blog.dana-farber.org/insight/2019/05/tips-for-staying-healthy-with-a-compromised-immune-system/

https://pmc.ncbi.nlm.nih.gov/articles/PMC8428766/

More information about
Infection in an immunocompromised host:

FAQ

Why don’t immunocompromised patients always show typical infection symptoms like redness and swelling?

When your immune system is weakened, it cannot mount the usual inflammatory response that causes visible signs like redness, swelling, and warmth at infection sites. These symptoms actually result from your immune system fighting the infection, so when that response is dampened, the classic signs may be absent even though infection is present. Sometimes fever is the only warning sign.[3]

Can antibody tests be trusted if I’m immunocompromised?

Antibody tests have important limitations for immunocompromised individuals. If your immune system cannot produce antibodies normally—particularly if you’re taking B-cell depleting drugs like rituximab—antibody tests may give falsely negative results even when you actually have an infection. For these patients, molecular tests that detect the pathogen directly are more reliable than tests looking for your immune response to it.[9]

What infections should immunocompromised patients be tested for that healthy people don’t worry about?

Immunocompromised patients need testing for opportunistic infections that rarely affect healthy people, including Pneumocystis pneumonia, symptomatic cytomegalovirus infections, widespread fungal infections like cryptococcosis and histoplasmosis, and certain parasites like Cryptosporidium. The specific infections to screen for depend on which part of your immune system is weakened.[4]

Why do I need so many diagnostic tests if I’m immunocompromised and get a fever?

Because infections can spread rapidly through your body when immune defenses are weak, comprehensive testing is needed to quickly identify the cause so appropriate treatment can begin immediately. What seems like a simple fever can progress to life-threatening sepsis within hours in severely immunocompromised patients, so doctors cast a wide net with multiple tests to catch the infection early before it becomes critical.[3]

Do I need different diagnostic tests depending on what type of immune problem I have?

Yes, the specific diagnostic approach depends on which part of your immune system is affected. If you have B-cell defects, doctors focus on testing for bacterial respiratory infections. T-cell problems require screening for fungal infections, certain viruses, and unusual bacteria. Phagocyte dysfunction means testing for staph infections and mold infections like Aspergillus. Your healthcare team tailors testing based on your specific immune deficiency type.[2]

🎯 Key takeaways

  • • Fever may be the only sign of serious infection in immunocompromised patients, as their weakened immune systems often cannot produce typical symptoms like redness and swelling at infection sites.[3]
  • • The type of immune deficiency you have determines which infections you’re most likely to develop, so diagnostic testing must be tailored to your specific immune system weakness.[1]
  • • Patients taking B-cell depleting drugs like rituximab need special molecular testing because their bodies cannot produce antibodies, making standard antibody tests unreliable.[9]
  • • Infections can progress from simple fever to life-threatening sepsis within hours in severely immunocompromised individuals, making immediate medical attention crucial.[3]
  • • Clinical trials require extensive baseline diagnostic testing to ensure participant safety and accurate interpretation of results, including immune function assessment, infection screening, and organ function tests.[2]
  • • Early diagnosis through prompt testing dramatically improves outcomes for immunocompromised patients with infections, emphasizing the importance of seeking medical care at the first sign of illness.[3]
  • • Nearly 7 million Americans have compromised immune systems, though many cases remain undiagnosed, highlighting the importance of recognizing who should be tested.[5]
  • • Different diagnostic approaches are needed for different types of immune deficiency—respiratory infection testing for B-cell problems, fungal and viral testing for T-cell issues, and bacterial culture for phagocyte dysfunction.[2]

Connected medications: